New pill HMPL-506 shows promise in early blood cancer trial
NCT ID NCT06387082
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 27 times
Summary
This study tests a new oral drug, HMPL-506, in about 132 adults with certain blood cancers (like leukemia) that have come back or not responded to treatment. The main goals are to check the drug's safety and find the right dose. Researchers will also look at whether the drug helps shrink or control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, China
Contact
Contact
-
Blood Diseases Hospital, Chinese Academy of medical Sciences
RECRUITINGTianjin, China
Contact
Contact
-
First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, China
Contact
Contact
-
Fujian Medical University Union Hospital
NOT_YET_RECRUITINGFuzhou, China
Contact
-
Henan Cancer Hospital
RECRUITINGZhengzhou, China
Contact
Contact
-
Nanfang Hospital, Southern Medical University
RECRUITINGGuangzhou, China
Contact
Contact
Contact
-
Qilu Hospital of Shandong University
RECRUITINGJinan, China
Contact
Contact
-
Shengjing Hospital of China Medical University
RECRUITINGShenyang, China
Contact
Contact
-
Sun Yat-sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, China
Contact
-
The Affiliated Hospital of Guizhou Medical University
NOT_YET_RECRUITINGGuiyang, China
Contact
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, China
Contact
-
The First Affiliated Hospital with Nanjing Medical University
RECRUITINGNanjing, China
Contact
Contact
-
The First Affiliated Hospital, Zhejiang University
RECRUITINGHangzhou, China
Contact
Contact
-
Tianjin People's Hospital
RECRUITINGTianjin, China
Contact
-
Wuhan Union Hospital of China
RECRUITINGWuhan, China
Contact
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.